arrow
D

Domenico Sergi

Department of Translational Medicine
H指数:25
被引数:1,899

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling

棕榈酸以不同方式调节SGBS脂肪细胞的细胞外囊泡和细胞脂肪酸组成,而不会损害其胰岛素信号传导。

2025-11-250
OAAI
Breast and cervical cancer in transgender men: literature review and a case report

跨性别男性乳腺癌和宫颈癌: 文献回顾和病例报告

2024-08-100
OAAI
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

基于MicroRNA的签名影响卵巢癌的临床过程和生物学: 一项miRNOmics研究

2021-07-1313
OAAI
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

ChangeHER试验中转移性乳腺癌HER2-positivity增益的预后相关性

2021-07-026
OAAI
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives

口咽和宫颈癌管理中的循环HPV DNA: 当前知识和未来前景

2021-04-0627
OAAI
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer

结直肠癌预后Wnt签名的多端口和跨平台验证

2020-12-291
OAAI
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

DNA损伤和修复生物标志物在接受新辅助激素治疗的老年激素受体阳性乳腺癌患者中的预后相关性: 来自真实世界的证据

2019-08-182
OAAI
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

帕妥珠单抗、曲妥珠单抗和紫杉烷类一线治疗晚期HER2阳性乳腺癌的多中心回顾性观察研究.RePer研究

2018-11-0730
OAAI
Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
2018-07-2210
OAAI
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
2018-05-1617
OAAI
The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression

进展期胃癌PD-L1依赖于ARID1A基因突变和ATM表达的临床意义

2018-03-2721
OAAI
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
2017-09-0616
OAAI
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy
2017-04-0719
OAAI